2011
DOI: 10.1111/j.1365-2125.2010.03847.x
|View full text |Cite
|
Sign up to set email alerts
|

Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment

Abstract: Pain is highly prevalent in frail older people who often have multiple co‐morbidities and multiple medicines. Rational prescribing of analgesics in frail older people is complex due to heterogeneity in drug disposition, comorbid medical conditions, polypharmacy and variability in analgesic response in this population. A critical issue in managing older people with pain is the need for judicious choice of analgesics based on a comprehensive medical and medication history. Care is needed in the selection of anal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
147
0
7

Year Published

2013
2013
2022
2022

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 185 publications
(164 citation statements)
references
References 150 publications
5
147
0
7
Order By: Relevance
“…People with frailty tend to have less predictable drug responses, increased drug sensitivity, and the potential for harmful side effects 51 . A recent review of the clinical pharmacology of analgesic medicines in older people with frailty, suggest that frailty may be predictive of an individual's pharmaco-kinetic and pharmacodynamics response, however, there are limited data examining this 54 .…”
Section: Discussionmentioning
confidence: 99%
“…People with frailty tend to have less predictable drug responses, increased drug sensitivity, and the potential for harmful side effects 51 . A recent review of the clinical pharmacology of analgesic medicines in older people with frailty, suggest that frailty may be predictive of an individual's pharmaco-kinetic and pharmacodynamics response, however, there are limited data examining this 54 .…”
Section: Discussionmentioning
confidence: 99%
“…The validity of a 'start low and go slow' approach has been called into question for this reason, i.e. that it leads to inadequate analgesia in patients who are already at higher risk of confusion and agitation [46]. However, pethidine is consistently associated with delirium, and should be avoided, as its metabolite norpethidine can cause excitement, agitation, twitching and tremors.…”
Section: Opioid Therapymentioning
confidence: 99%
“…However, pethidine is consistently associated with delirium, and should be avoided, as its metabolite norpethidine can cause excitement, agitation, twitching and tremors. Frail and cognitively impaired patients do not appear to have reduced pain perception and hence appear to require similar doses of analgesia to ablate pain, although more research is needed to confirm this [46] and analgesia should be prescribed with particular caution to these groups [63]. Buprenorphine may be a more appropriate choice of opioid for patients with renal disease, as its pharmacokinetics are unaltered by renal function [49].…”
Section: Opioid Therapymentioning
confidence: 99%
See 1 more Smart Citation
“…Chronological age has also been cited as an important predictor of analgesic response [36]. However, the paucity of evidence relating pharmacodynamic responses to frailty is acknowledged as a limiting factor in establishing optimal dosing regimes in this patient group [37].…”
Section: Pharmacodynamic Changesmentioning
confidence: 99%